AstraZeneca have opened a pioneering new Learning Academy at the pharmaceutical company’s Macclesfield Campus.
The new facility is linked to investment in a £280 million advanced medicine manufacturing facility announced in April last year to meet rising global demand for AstraZeneca’s oncology medicine Zoladex.
The Academy brings together state-of-the-art virtual reality training technology, induction training and equipment mock-ups under one roof in a new purpose-built facility.
The Learning Academy was officially opened with a ribbon-cutting ceremony which was attended by employees involved in its development, AstraZeneca’s Head of UK Operations Fredrik Åsell, as well as David Rutley, Work and Pensions Minister and MP for Macclesfield.
Fredrik Åsell said:
“The opening of our new Learning Academy is another key step in making sure we can deliver the life-saving drugs our patients need across the globe. Through the use of cutting-edge technology we can help our teams build expertise in complex sterile manufacture more quickly and efficiently ”
David Rutley MP said:
“It is a great honour to have been invited to formally open this new Learning Academy. This is another step in the exciting journey of enhancing the Zoladex processes at AstraZeneca’s Macclesfield Campus. This highly skilled local team plays a vital role in helping the company achieve its global ambitions, as the treatment improves the lives of millions of patients throughout the world. I am grateful for the significant investment that has taken place over recent years – it is an important engine for our local economy.”
Photo: AstraZeneca Head of UK Operations, Fredrik Åsell (L) and Macclesfield MP, David Rutley (R) at the unveiling of the new Learning Academy.
MAG subsidiary acquires European airport parking marketplace 
North West Hydrogen industry gears up for third annual Hydrogen Week 
Female Founders Incubator launches at Alderley Park